ArticleDrug delivery2019

Combined using of paclitaxel and salinomycin active targeting nanostructured lipid carriers against non-small cell lung cancer and cancer stem cells.

Jianwen Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.